Get the Stockscreener App
38.48
4.88%
1.79
Conmed Corp stock is traded at $38.48, with a volume of 1.40M.
It is up +4.88% in the last 24 hours and up +6.01% over the past month.
Conmed Corp is a medical technology company that provides devices and equipment for surgical procedures. The company's products are used by surgeons and other healthcare professionals across specialties, including orthopedics, general surgery, gynecology, thoracic surgery, and gastroenterology. Geographically, the company operates in the United States, Europe, the Middle East & Africa, Asia Pacific, and the Americas, excluding the United States. The majority of revenue is generated from the United States.
See More
Previous Close:
$36.69
Open:
$37.3
24h Volume:
1.40M
Relative Volume:
2.67
Market Cap:
$1.16B
Revenue:
$1.37B
Net Income/Loss:
$54.85M
P/E Ratio:
21.70
EPS:
1.7729
Net Cash Flow:
$123.71M
1W Performance:
+13.75%
1M Performance:
+6.01%
6M Performance:
-10.32%
1Y Performance:
-28.17%
1-Day Range:
$36.41
$38.83
1-Week Range:
$32.64
$38.83
52-Week Range:
$31.44
$56.63
Conmed Corp Stock (CNMD) Company Profile
Name
Conmed Corp
Sector
Industry
Phone
727-214-2974
Address
11311 CONCEPT BOULEVARD, LARGO, NY
Compare CNMD vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CNMD
Conmed Corp
|
38.48 | 1.10B | 1.37B | 54.85M | 123.71M | 1.7729 |
ABT
Abbott Laboratories
|
93.93 | 164.43B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
329.78 | 125.40B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
83.87 | 105.46B | 36.36B | 4.84B | 5.43B | 3.7212 |
BSX
Boston Scientific Corp
|
44.77 | 66.87B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
92.21 | 52.59B | 6.30B | 1.07B | 1.09B | 1.8406 |
Conmed Corp Stock (CNMD) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-17-26 | Downgrade | Piper Sandler | Overweight → Neutral |
| Jun-12-25 | Downgrade | Needham | Buy → Hold |
| Apr-28-25 | Downgrade | Stifel | Buy → Hold |
| Feb-06-25 | Downgrade | JP Morgan | Overweight → Neutral |
| Feb-01-24 | Reiterated | Needham | Buy |
| May-22-23 | Initiated | CL King | Buy |
| Mar-27-23 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Mar-21-23 | Initiated | Wells Fargo | Equal Weight |
| Oct-12-22 | Initiated | Jefferies | Hold |
| Mar-02-22 | Resumed | BofA Securities | Neutral |
| Oct-06-21 | Upgrade | Needham | Hold → Buy |
| Jul-15-21 | Initiated | UBS | Buy |
| May-25-21 | Initiated | Barclays | Overweight |
| Nov-26-19 | Downgrade | Needham | Buy → Hold |
| Nov-12-19 | Initiated | JP Morgan | Overweight |
| Oct-31-19 | Reiterated | Needham | Buy |
| Oct-04-19 | Reiterated | Needham | Buy |
| Aug-22-19 | Upgrade | Piper Jaffray | Neutral → Overweight |
| Apr-18-19 | Initiated | Stifel | Buy |
| Apr-16-19 | Reiterated | Needham | Buy |
| Jan-23-19 | Reiterated | Needham | Buy |
| Oct-16-18 | Initiated | Barclays | Equal Weight |
| Aug-07-18 | Reiterated | Needham | Buy |
| Aug-02-18 | Reiterated | Needham | Buy |
| Apr-26-18 | Reiterated | Needham | Buy |
| Feb-01-18 | Reiterated | Needham | Buy |
| Jul-27-17 | Reiterated | Needham | Buy |
| Apr-27-17 | Downgrade | Ladenburg Thalmann | Buy → Neutral |
| Apr-27-17 | Reiterated | Needham | Buy |
| Nov-18-16 | Reiterated | Needham | Buy |
| Jul-28-16 | Downgrade | Leerink Partners | Outperform → Mkt Perform |
| Apr-28-16 | Reiterated | Needham | Buy |
| Oct-22-15 | Reiterated | Northland Capital | Market Perform |
View All
Conmed Corp Stock (CNMD) Latest News
A Look at Conmed Corp (CNMD) After 4.9% Gain -- GF Value $74.38 vs Price $38.48 - GuruFocus
Conmed shares jump on potential sale report - Investing.com
Conmed shares jump on potential sale report By Investing.com - Investing.com UK
CONMED (NYSE:CNMD) Upgrade Puts Recovery In Focus - Kalkine Media
CONMED (NYSE:CNMD) Upgraded at BMO Capital Markets - MarketBeat
CONMED (NYSE:CNMD) Stock Price Up 11.6%Still a Buy? - MarketBeat
CNMD stock holds steady as focus shifts to the business - Ad-hoc-news.de
CONMED (CNMD) Stock Fair Value Moves Lower As Analysts Turn More Cautious - Yahoo Finance
CONMED stock centers on its medical device platform - Ad-hoc-news.de
CONMED (NYSE:CNMD) Sparks Value Debate After Slide - Kalkine Media
CONMED Corporation (CNMD) Rallies 3.27% as Support Holds FirmPairs Trade - dars.gov.et
Form 4 CONMED Corporation For: 2 July By Investing.com - Investing.com Canada
Director at CONMED (CNMD) receives grant of 5,603 restricted stock units - Stock Titan
Director Jeffrey Mirviss granted 5,603 RSUs at CONMED (NYSE: CNMD) - Stock Titan
New CONMED (CNMD) director Jeffrey Mirviss reports no common stock holdings - Stock Titan
New CONMED (CNMD) director Celine Christine Martin reports no common stock holdings - Stock Titan
CONMED schedules Q2 results call for July 29 after market close - Stock Titan
Why CONMED (CNMD) Shares Are Falling Today - Yahoo! Finance Canada
BofA downgrades Conmed stock rating on growth concerns - Investing.com
Here's why you should retain CONMED stock in your portfolio now - MSN
CNMD Forecast — Price Target — Prediction for 2027 - TradingView
Conmed Corp (CNMD) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
CNMD Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Will CONMED’s New CFO Shift CNMD’s Financial Playbook Or Deepen Its Existing Strategy? - Yahoo Finance
CONMED Corp. Stock Plummets to New 52-Week Low of $31.86 - MarketsMojo
CONMED Corp. Stock Hits Day Low of $31.86 Amid Price Pressure - MarketsMojo
Conmed Corp (CNMD) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
CONMED Appoints John E. Gallagher as New Chief Financial Officer, Effective July 2026 - Minichart
Conmed Corp (CNMD) Valuation: PE, PB & Fair Value Analysis - TradingKey
Conmed Corp (CNMD) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Conmed Corp (CNMD) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Conmed Corp (CNMD) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Conmed Corp (CNMD) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Conmed Corp (CNMD) Institutional Confidence - TradingKey
Conmed Corp (CNMD) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Conmed names John Gallagher as CFO effective July 15 - Investing.com
CONMED names John E. Gallagher as EVP & CFO, Patrick Beyer steps down as interim PFO - TradingView
CONMED (NYSE: CNMD) hires John Gallagher as CFO with equity-heavy pay - Stock Titan
Conmed names John Gallagher as CFO effective July 15 By Investing.com - Investing.com UK
CONMED picks John Gallagher as CFO in July leadership change - Stock Titan
Conmed Corporation stock hits 52-week low at 32.1 USD - Investing.com
Discipline and Rules-Based Execution in CNMD Response - Stock Traders Daily
CONMED Corp stock (US2074101013): Medtech mid-cap in focus after latest earnings and guidance update - AD HOC NEWS
CONMED Corp stock (US2074101013): medtech growth story after latest earnings update - Ad-hoc-news.de
CONMED to Repurchase $645.2 Million of 2027 Convertible Notes for $637.2 Million Cash - TradingView
CONMED (CNMD) to buy back $645.2M of 2.25% convertible notes due 2027 - Stock Titan
Director at CONMED (NYSE: CNMD) exercises 668 RSUs and receives 5,772-unit equity award - Stock Titan
CONMED (NYSE: CNMD) director gets 5,772 RSUs, converts 668 units - Stock Titan
Director at CONMED (NYSE: CNMD) receives 5,772 RSUs under 2025 incentive plan - Stock Titan
CONMED (NYSE: CNMD) director awarded 5,772 RSUs and exercises 668 into shares - Stock Titan
Director Mark Kaye receives 5,772 RSUs at CONMED (NYSE: CNMD) - Stock Titan
Conmed Corp Stock (CNMD) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.36%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):